Feasibility of atomic force microscopy for determining crystal growth rates of nifedipine at the surface of amorphous solids with and without polymers

Journal of Pharmaceutical Sciences

Volumn 100, Issue 10, 2011, Pages 4413-4420

  Miyazaki, Tamaki ^a   Aso, Yukio ^a   Kawanishi, Toru ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Amorphous; Crystallization; Excipients; Microscopy; Physical stability; Solid dispersion

Indexed keywords

ALPHA,BETA POLY(N 5 HYDROXYPENTYL)ASPARTAMIDE; MACROGOL; NIFEDIPINE; POLYMER; UNCLASSIFIED DRUG; EXCIPIENT; MACROGOL DERIVATIVE;

ARTICLE; ATOMIC FORCE MICROSCOPY; CRYSTALLIZATION; DISPERSION; GROWTH RATE; MICROSCOPY; POLARIZED LIGHT MICROSCOPY; ROOM TEMPERATURE; SURFACE PROPERTY; THREE DIMENSIONAL IMAGING; CHEMISTRY; COMPARATIVE STUDY; EVALUATION STUDY; FEASIBILITY STUDY; KINETICS; MEDICINAL CHEMISTRY; PHARMACEUTICS; POLARIZATION MICROSCOPY; PROCEDURES;

CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; EXCIPIENTS; FEASIBILITY STUDIES; KINETICS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, POLARIZATION; NIFEDIPINE; POLYETHYLENE GLYCOLS; POLYMERS; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL;

EID: 80052261590     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22603     Document Type: Article

References (16)

1. Bunjes H, Rades T. 2005. Thermotropic liquid crystalline drugs. J Pharm Pharmacol 57:807-816.
2. Murdande SB, Pikal MJ, Shanker RM, Bogner RH. 2001. Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis. J Pharm Sci 99:1254-1264.
3. Blagden N, de Matas M, Gavan PT, York P. 2007. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev 59:617-630.
4. g. Pharm Res 23:2350-2355.
5. Zhu L, Wong L, Yu L. 2008. Surface-enhanced crystallization of amorphous nifedipine. Mol Pharm 5:921-926.
6. Liao X, Wiedmann TS. 2006. Formation of cholesterol crystals at a mucin coated substrate. Pharm Res 23:2413-2416.
7. Cassidy AM, Gardner CE, Jones W. 2009. Following the surface response of caffeine cocrystals to controlled humidity storage by atomic force microscopy. Int J Pharm 379:59-66.
8. Price R, Young PM. 2004. Visualization of the crystallization of lactose from the amorphous state. J Pharm Sci 93:155-164.
9. Mahlin D, Berggren J, Alderborn G, Engström S. 2004. Moisture-induced surface crystallization of spray-dried amorphous lactose particles studied by atomic force microscopy. J Pharm Sci 93:29-37.
10. Mahlin D, Berggren J, Gelius U, Engström S, Alderborn G. 2006. The influence of PVP incorporation on moisture-induced surface crystallization of amorphous spray-dried lactose particles. Int J Pharm 321:78-85.
11. Chan KL, Kazarian SG. 2004. FTIR spectroscopic imaging of dissolution of a solid dispersion of nifedipine in poly(ethylene glycol). Mol Pharm 1:331-335.
12. Vippagunta SR, Wang Z, Hornung S, Krill SL. 2007. Factors affecting the formation of eutectic solid dispersions and their dissolution behavior. J Pharm Sci 96:294-304.
13. Bley H, Fussnegger B, Bodmeier R. 2010. Characterization and stability of solid dispersions based on PEG/polymer blends. Int J Pharm 390:165-173.
14. 1H-NMR spin-lattice relaxation. Chem Pharm Bull 55:1227-1231.
15. Rumondor AC, Marsac PJ, Stanford LA, Taylor LS. 2009. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Mol Pharm 6:1492-1505.
16. Giammona G, Carlisi B, Plazzo S. 1987. Reaction of α, β-poly(N-hydroxyethyl)-dl-aspartamide with derivatives of carboxylic acids. J Polym Sci Polym Chem Ed 25:2813-2818.